NEW YORK, N.Y. – Pfizer has awarded almost $500,000 to Brigham and Women’s Hospital for a clinical trial that will test whether the combination of a smartphone app and population management system will improve patient satisfaction and management for rheumatoid arthritis patients. About 190 women will be enrolled in the study. Half of the participants will use the app, which will ask daily questions about their pain, function and disease activity; and the other half will receive the usual course of care. The study will conclude in September 2018.
You are here: / / Pfizer supports app study